Cargando…
Gene signature predictive of hepatocellular carcinoma patient response to transarterial chemoembolization
Transarterial chemoembolization (TACE) is a commonly used treatment modality in hepatocellular carcinoma (HCC). The ability to identify patients who will respond to TACE represents an important clinical need, and tumor gene expression patterns may be associated with TACE response. We investigated wh...
Autores principales: | Fako, Valerie, Martin, Sean P., Pomyen, Yotsawat, Budhu, Anuradha, Chaisaingmongkol, Jittiporn, Franck, Sophia, Lee, Joyce Man-Fong, Ng, Irene Oi-Lin, Cheung, Tan-To, Wei, Xiyang, Liu, Niya, Ji, Junfang, Zhao, Lei, Liu, Zhaogang, Jia, Hu-Liang, Tang, Zhao-You, Qin, Lun-Xiu, Kloeckner, Roman, Marquardt, Jens, Greten, Tim, Wang, Xin Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854367/ https://www.ncbi.nlm.nih.gov/pubmed/31754337 http://dx.doi.org/10.7150/ijbs.39534 |
Ejemplares similares
-
Tumor metabolism and associated serum metabolites define prognostic subtypes of Asian hepatocellular carcinoma
por: Pomyen, Yotsawat, et al.
Publicado: (2021) -
Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
por: Kloeckner, Roman, et al.
Publicado: (2015) -
Gut dysbiosis in Thai intrahepatic cholangiocarcinoma and hepatocellular carcinoma
por: Pomyen, Yotsawat, et al.
Publicado: (2023) -
PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma
por: Martin, Sean P., et al.
Publicado: (2020) -
The Addition of Transarterial Chemoembolization to Palliative Chemotherapy Extends Survival in Intrahepatic Cholangiocarcinoma
por: Gairing, Simon Johannes, et al.
Publicado: (2021)